A Human iPSC-Derived Neuron and Cardiomyocyte Platform for Assessing Novel Recombinant Adeno-Associated Viral (AAV) Vectors
Publication
, Conference
Jeon, K; Gold, S; Hu, M; Smith, JK; O'Banion, C; Morra, M; Luongo, TS; Asokan, A; Graef, JD
Published in: MOLECULAR THERAPY
2022
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2022
Volume
30
Issue
4
Start / End Page
482 / 482
Related Subject Headings
- Biotechnology
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Jeon, K., Gold, S., Hu, M., Smith, J. K., O’Banion, C., Morra, M., … Graef, J. D. (2022). A Human iPSC-Derived Neuron and Cardiomyocyte Platform for Assessing Novel Recombinant Adeno-Associated Viral (AAV) Vectors. In MOLECULAR THERAPY (Vol. 30, pp. 482–482).
Jeon, Kilsoo, Stephanie Gold, Mei Hu, J Kennon Smith, Colin O’Banion, Marc Morra, Tim S. Luongo, Aravind Asokan, and John D. Graef. “A Human iPSC-Derived Neuron and Cardiomyocyte Platform for Assessing Novel Recombinant Adeno-Associated Viral (AAV) Vectors.” In MOLECULAR THERAPY, 30:482–482, 2022.
Jeon K, Gold S, Hu M, Smith JK, O’Banion C, Morra M, et al. A Human iPSC-Derived Neuron and Cardiomyocyte Platform for Assessing Novel Recombinant Adeno-Associated Viral (AAV) Vectors. In: MOLECULAR THERAPY. 2022. p. 482–482.
Jeon, Kilsoo, et al. “A Human iPSC-Derived Neuron and Cardiomyocyte Platform for Assessing Novel Recombinant Adeno-Associated Viral (AAV) Vectors.” MOLECULAR THERAPY, vol. 30, no. 4, 2022, pp. 482–482.
Jeon K, Gold S, Hu M, Smith JK, O’Banion C, Morra M, Luongo TS, Asokan A, Graef JD. A Human iPSC-Derived Neuron and Cardiomyocyte Platform for Assessing Novel Recombinant Adeno-Associated Viral (AAV) Vectors. MOLECULAR THERAPY. 2022. p. 482–482.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2022
Volume
30
Issue
4
Start / End Page
482 / 482
Related Subject Headings
- Biotechnology
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences